Cargando…
Survival Pathways of HIF-Deficient Tumour Cells: TCA Inhibition, Peroxisomal Fatty Acid Oxidation Activation and an AMPK-PGC-1α Hypoxia Sensor
The HIF-1 and HIF-2 (HIF1/2) hypoxia responses are frequently upregulated in cancers, and HIF1/2 inhibitors are being developed as anticancer drugs. How could cancers resist anti-HIF1/2 therapy? We studied metabolic and molecular adaptations of HIF-1β-deficient Hepa-1c4, a hepatoma model lacking HIF...
Autores principales: | Golinska, Monika A., Stubbs, Marion, Harris, Adrian L., Boros, Laszlo G., Basetti, Madhu, McIntyre, Dominick J. O., Griffiths, John R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688062/ https://www.ncbi.nlm.nih.gov/pubmed/36429023 http://dx.doi.org/10.3390/cells11223595 |
Ejemplares similares
-
The action of β-hydroxybutyrate on the growth, metabolism and global histone H3 acetylation of spontaneous mouse mammary tumours: evidence of a β-hydroxybutyrate paradox
por: Rodrigues, Loreta M., et al.
Publicado: (2017) -
Proline-Hydroxylated Hypoxia-Inducible Factor 1α (HIF-1α) Upregulation in Human Tumours
por: Snell, Cameron E., et al.
Publicado: (2014) -
Phosphorylation of PDHA by AMPK Drives TCA Cycle to Promote Cancer Metastasis
por: Cai, Zhen, et al.
Publicado: (2020) -
Exploration of human brain tumour metabolism using pairwise metabolite-metabolite correlation analysis (MMCA) of HR-MAS (1)H NMR spectra
por: Madhu, Basetti, et al.
Publicado: (2017) -
Metabolomic changes during cellular transformation monitored by metabolite–metabolite correlation analysis and correlated with gene expression
por: Madhu, Basetti, et al.
Publicado: (2015)